Patent details
EP3877513 Title: PROCESSES FOR PRODUCTION OF TUMOR INFILTRATING LYMPHOCYTES AND USES OF THE SAME IN IMMUNOTHERAPY
Basic Information
- Publication number:
- EP3877513
- PCT Application Number:
- US2019059718
- Type:
- European Patent Granted for LU
- Legal Status:
- Unitary Effect Registered
- Application number:
- EP198366486
- PCT Publication Number:
- WO2020096988
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- PROCESSES FOR PRODUCTION OF TUMOR INFILTRATING LYMPHOCYTES AND USES OF THE SAME IN IMMUNOTHERAPY
- French Title of Invention:
- PROCÉDÉS DE PRODUCTION DE LYMPHOCYTES INFILTRANT LES TUMEURS ET LEURS UTILISATIONS EN IMMUNOTHÉRAPIE
- German Title of Invention:
- VERFAHREN ZUR HERSTELLUNG VON TUMORINFILTRIERENDEN LYMPHOZYTEN UND VERWENDUNGEN DAVON IN DER IMMUNTHERAPIE
- SPC Number:
Unitary Effect
- Unitary Effect Requested:
- Yes
- Unitary Effect Request Filing Date:
- 05/06/2025
- Link to UPP Register:
- European Patent Register
- Unitary Effect Request Withdrawal Date:
- Unitary Effect Status:
- Unitary Effect Registered
- Unitary Effect Acceptance Decision Date:
- 16/06/2025
- Unitary Effect Rejection Decision Date:
- Unitary Effect Date:
- 07/05/2025
- Unitary Effect Registration Date:
- 16/06/2025
- Unitary Effect Re-establishment of rights Filing Date:
- Unitary Effect Re-establishment of rights EPO Decision :
- Unitary Effect Re-establishment of rights EPO Decision Date:
- Explanatory Text UE:
- Safety Net Request Date:
- Safety Net Decision Date:
- Safety Net Decision Outcome:
- SPC Number:
Dates
- Filing date:
- 04/11/2019
- Grant date:
- 07/05/2025
- EP Publication Date:
- 15/09/2021
- PCT Publication Date:
- 14/05/2020
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 07/05/2025
- EP B1 Publication Date:
- 07/05/2025
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 04/11/2039
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 30/04/2025
- Name:
- Iovance Biotherapeutics, Inc.
- Address:
- 825 Industrial Road Suite 400, San Carlos, CA 94070, United States (US)
Inventor
1
- Name:
- WARDELL, Seth
- Address:
- United States (US)
2
- Name:
- MORENO, Maritza Lienlaf
- Address:
- United States (US)
Priority
1
- Priority Number:
- 201862755954 P
- Priority Date:
- 05/11/2018
- Priority Country:
- United States (US)
2
- Priority Number:
- 201962903585 P
- Priority Date:
- 20/09/2019
- Priority Country:
- United States (US)
Classification
- IPC classification:
- A61K 9/00; A61K 38/20; A61P 35/00; A61K 39/00; C12N 5/0783;
Publication
European Patent Bulletin
1
- Issue number:
- 202519
- Publication date:
- 07/05/2025
- Description:
- Grant (B1)
2
- Issue number:
- 202528
- Publication date:
- 09/07/2025
- Description:
- Unitary Effect Request Receipt
3
- Issue number:
- 202529
- Publication date:
- 16/07/2025
- Description:
- Unitary Effect Request Acceptance
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|